Exane Derivatives’s S&P Global SPGI Stock Holding History

Exane Derivatives’s Portfolio SPGI Stock Details SPGI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$693K	Sell	2,055 -26	-1%	-$9.27K	0.4%	57
2022 Q1	$854K	Sell	2,081 -481	-19%	-$196K	0.24%	113
2021 Q4	$1.21M	Sell	2,562 -1,441	-36%	-$659K	0.29%	70
2021 Q3	$1.7M	Sell	4,003 -266	-6%	-$115K	0.41%	46
2021 Q2	$1.75M	Buy	4,269 +286	+7%	+$110K	0.4%	48
2021 Q1	$1.41M	Buy	3,983 +182	+5%	+$60.6K	0.4%	56
2020 Q4	$1.25M	Buy	3,801 +32	+0.8%	+$10.8K	0.37%	55
2020 Q3	$1.36M	Hold	3,769	–	–	0.39%	54
2020 Q2	$1.24M	Hold	3,769	–	–	0.33%	81
2020 Q1	$924K	Sell	3,769 -668	-15%	-$183K	0.26%	84
2019 Q4	$1.31M	Sell	4,437 -297	-6%	-$77.2K	0.24%	98
2019 Q3	$1.16M	Buy	4,734 +3,170	+203%	+$792K	0.21%	96
2019 Q2	$356K	Buy	+1,564	New	+$342K	0.06%	205

Other funds holding SPGI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Exane Derivatives's SPGI Position: Q2 2022 in Review

Exane Derivatives reduced its S&P Global (SPGI) stake by 1.2% in Q2 2022, selling an estimated $9.27K and leaving 2,055 shares worth $693K. The position accounts for 0.4% of the portfolio, ranked #57.

Exane Derivatives first reported a position in SPGI in Q2 2019 and has held it in 13 quarters since. The position peaked at $1.75M in Q2 2021. 1,557 funds tracked by Wall St. Rank hold SPGI as of Q2 2022.

Exane Derivatives held 2,055 shares of S&P Global worth $693K as of Q2 2022.
Exane Derivatives sold 26 S&P Global shares in Q2 2022, an estimated $9.27K.
S&P Global made up 0.4% of Exane Derivatives's portfolio in Q2 2022, its #57 holding.
Exane Derivatives first reported a position in S&P Global in Q2 2019 and has held it in 13 quarters since.
Exane Derivatives's S&P Global position peaked at $1.75M in Q2 2021.
1,557 funds tracked by Wall St. Rank held S&P Global as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.